Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membrane phospholipids and anionic cell surface components serve as critical structural and functional elements of the bacterial cell envelope. In Gram-negative bacteria, the primary anionic component is lipopolysaccharide (LPS) located in the outer membrane, while Gram-positive bacteria utilize lipoteichoic acids (LTA) and acidic phospholipids like phosphatidylglycerol and cardiolipin. These molecules provide a net negative charge to the microbial surface, which is essential for maintaining membrane stability, regulating ion transport, and protecting the cell from environmental stressors. Because human cell membranes are predominantly composed of neutral zwitterionic lipids like phosphatidylcholine, these anionic microbial components represent a highly selective target for various antimicrobial agents. Therapeutic agents such as polymyxins and daptomycin exploit the electrostatic difference between host and pathogen surfaces to achieve selective toxicity. Polymyxins bind to the lipid A portion of LPS in Gram-negative bacteria, disrupting the outer membrane, while daptomycin inserts into the cytoplasmic membrane of Gram-positive bacteria in a calcium-dependent manner. This interaction leads to the formation of transmembrane pores or general membrane destabilization, resulting in the leakage of essential ions like potassium, loss of membrane potential, and rapid bacterial cell death. These components are vital targets in the treatment of multi-drug resistant infections, although their clinical use requires careful monitoring due to potential toxicities associated with high systemic concentrations.
Drugs targeting these components typically act via electrostatic attraction to negatively charged surfaces (like LPS or LTA), followed by insertion into the lipid bilayer, leading to membrane depolarization, pore formation, and leakage of intracellular contents, ultimately causing rapid cell death.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane phospholipids and anionic cell surface components.